In vitro phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (Maraviroc): TROPI-CO study
S. GRACIAS, I. El Yaalaoui, B. Visseaux, C. charpentier, D. Diane, C. Martin, F. Lermechain, J.-C. Plantier, E. Alessandri-Gradt
This study evaluates the phenotypic susceptibility of HIV-1 non-group M strains to Maraviroc, showing variability linked to tropism and highlighting the need for additional parameters beyond IC50 values.
bioRxiv · Oct 20, 2023 · PreprintMicrobiology